Scimeca Warns: The Rising Impact of Mass Tort Litigation on Economic Well-being

Boston, MA — Across the United States, mass tort litigation is soaring, leading many experts to debate its impact on the economy and society. These complex legal battles, often encompassing hundreds or thousands of plaintiffs against one or more corporate defendants, are not just about enormous settlements; they’re about a cost that trickles down to consumers and manifests in various unexpected ways, from product prices to insurance premiums. These lawsuits typically arise when consumers suffer injuries or damages due to defective products, pharmaceuticals, or environmental disasters. The litigation is intended to ensure justice for aggrieved … Read more

Domnick Cunningham & Yaffa Targets National Growth with High-Profile Addition and Expansion into Mass Tort Litigation

WEST PALM BEACH, Fla. — In a strategic move to broaden its legal competencies, the prominent catastrophic injury law firm Domnick Cunningham & Yaffa announced its expansion into mass tort law, an area dealing with civil actions involving numerous plaintiffs against one or a few corporate defendants in state or federal court. This move will include welcoming highly regarded attorney Troy Rafferty as a new shareholder. The firm, rebranded as Rafferty Domnick Cunningham & Yaffa (RDCY), marks a significant turn in its mission to champion client rights on a national scale. Troy Rafferty, previously associated … Read more

Bankruptcy Surge in Mass Tort Cases Sparks Debate Over Fairness in Equity

New York — As corporations increasingly opt for bankruptcy in response to mass litigation claims, concerns are mounting about the implications for plaintiffs who allege harm from products or corporate practices. This emerging trend in litigation can potentially shift the balance and dynamics of massive tort cases, traditionally settled or decided in court, to the realm of bankruptcy courts, inviting an examination of fairness and equity in these proceedings. The phenomenon arises as companies confront allegations ranging from environmental damages to consumer product hazards. When faced with an overwhelming number of lawsuits, some corporations choose … Read more

$1.1 Billion Risperdal Settlement a Landmark Victory for Plaintiffs in Philadelphia’s Mass Tort History

Philadelphia, PA — The sprawling legal battle over Risperdal, once involving over 7,000 cases, has largely concluded with settlements that encompass a total of up to $1.1 billion. The litigation revolved around allegations that the drug, often prescribed off-label, led to the development of gynecomastia in young men and boys, a condition characterized by the growth of breast tissue. The resolution of these cases marked a significant moment in the city’s Complex Litigation Center, noted for handling one of the largest mass torts in its history. This litigation was notable not only for its size … Read more